Copper-peptide percentages: what the label does and does not tell you

Write down the noun next to the number

Start with the exact wording. “Copper peptide,” “GHK-Cu,” “GHK,” and “peptide complex” should not be silently substituted for one another. If a supplier’s mixture is involved, a percentage of that mixture may describe something different from the percentage of a specific ingredient within it.

You do not need to solve the formulation yourself. You need to identify what is explicit and what remains a question. Ask the manufacturer or, for a prescribed compound, the prescriber and dispensing pharmacy to clarify the ingredient identity and percentage basis.

Our CoreAge review records “Copper Peptide 2%” as the provider’s wording. The public page did not give enough information for us to independently restate it as a precise pure-GHK-Cu concentration.

A ratio can describe two different ingredients

NIOD CAIS3 is a useful example because the company describes 1% GHK-Cu alongside 1% GHK. The copper-containing peptide and the additional peptide are distinguished in its own explanation.

Adding the two values and calling the sum “2% copper” would change the meaning. It would also confuse an ingredient concentration with elemental copper content. A finished serum is not described accurately by reducing every copper-associated name to the same substance.

This is a label-reading issue before it is a scientific one. Preserve the manufacturer’s distinction first. If chemical identity or formulation basis remains unclear, that uncertainty belongs in the comparison rather than being filled with a guess.

Ingredient order offers clues, not a recipe

FDA’s Cosmetics Labeling Guide explains the general order-of-predominance rule. It also permits ingredients present at concentrations of 1% or less to be listed in any order after ingredients present above 1%, with additional rules for color additives and other circumstances.

That exception prevents a common shortcut: reading a later ingredient’s exact percentage from its place in the list. Two ingredients next to each other do not necessarily have similar concentrations. A name near the end is not, on its own, evidence that the product cannot have an effect.

These are general US cosmetic-labeling principles, not a legal determination about a particular product. A prescription compound can require a different set of questions about its dispensed label and formula. Do not assume that a retail cosmetic list and a pharmacy label use identical conventions.

Missing percentages have a limited meaning

Biossance’s serum lists Copper Tripeptide-1 without establishing its percentage in the public page we reviewed. We can say the ingredient is declared. We cannot manufacture an amount from its position or from the color of the liquid.

Lack of a disclosed percentage does not prove that a formula is weak. Conversely, disclosure of a larger percentage does not establish greater effectiveness, better tolerance, or greater delivery into skin. Those outcomes require other evidence about the complete formulation and its use.

The same restraint applies to proprietary blend names. A brand may have a descriptive name for a group of ingredients, but the name alone does not disclose every component’s amount. It is reasonable to ask what the stated percentage includes.

Blue is a visual property, not an assay

Some copper-peptide serums are blue, and manufacturers may explain that appearance in their product descriptions. A shopper’s visual impression cannot independently establish a concentration, purity, stability, or clinical benefit.

Photos introduce more uncertainty through lighting, screens, and editing. Even an unedited photo is not a chemical measurement. We therefore do not compare products by how intensely blue their marketing images look.

Our label lens uses a clearly marked teaching example rather than a simulated bottle test. It separates the front label, ingredient identity, formulation base, and result claim so that the artwork does not imply an analysis we did not perform.

Percentage is only one part of a buying decision

The complete product includes its base, packaging, directions, and intended use. A cream with a named active and a serum with the same broad ingredient category may fit different routines. The base fieldnote explains why texture and hydration questions should not disappear behind the headline number.

Evidence has its own requirements. A study of one product cannot automatically validate another concentration or another formulation. Read the human-evidence guide for the difference between a plausible ingredient mechanism and a demonstrated result from a finished product.

Price needs a separate comparison too. A bottle price, a promotional price, and a starting monthly service fee should not be ranked as though they describe equal quantities and conditions.

Keep a short record before you buy

Record the full product name, the exact percentage wording, the ingredient list or pharmacy formulation, the selected size, and the current directions. Then note the questions the page does not answer. That record is often more useful than another unqualified “strongest copper peptide” list.

For prescriptions, bring those questions to the treating team. For retail cosmetics, use the manufacturer’s current product support and retain the packaging. The purpose is to replace a guess with an answer, not to calculate a personal dose from a marketing percentage.